secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0001048477-25-000086
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin appoints Ian T. Clark to Board of Directors effective August 1, 2025
-----------------------------------------------------------------------------

- Board size increased from ten to eleven members to accommodate Clark's appointment.
- Clark appointed to Audit Committee and Science and Technology Committee.
- Received RSU grant valued at $400,000 under 2017 Equity Incentive Plan.
- Will receive standard non-employee director fees and committee retainers as outlined in proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000104847725000086/0001048477-25-000086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000104847725000086/bmrn-20250730.htm
  HTML page:      https://secwatch.observer/filing/0001048477-25-000086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer